Buspirone for early satiety and symptoms of gastroparesis: A multi-centre, randomised, placebo-controlled, double-masked trial (BESST)

for the NIDDK Gastroparesis Clinical Research Consortium

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Buspirone for early satiety and symptoms of gastroparesis: A multi-centre, randomised, placebo-controlled, double-masked trial (BESST)'. Together they form a unique fingerprint.

Medicine & Life Sciences